<DOC>
	<DOC>NCT01391299</DOC>
	<brief_summary>This study evaluated the safety and efficacy of botulinum toxin Type A compared to placebo for the treatment of forehead lines (facial rhytides) when also administered to frown lines (glabellar rhytides).</brief_summary>
	<brief_title>Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Moderate to severe forehead lines Current or previous botulinum toxin treatment of any serotype within one year Diagnosis of myasthenia gravis, EatonLambert syndrome, amyotrophic lateral sclerosis Prior facial cosmetic surgery (e.g. prior periorbital surgery, facial lift, brow lift, eyelid lift or eyebrow surgery) Facial laser or light treatment, microdermabrasion, or superficial peels within 3 months Oral retinoid therapy within one year</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>